Records containing: Prostate Cancer

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2023-08-08
Improvement of Robotic-assisted Radical Prostatectomy (RARP) Outcomes Via Automatedly Segmented 3D Printed and Virtual Prostate Models: a Feasibility Study
CLINICAL_TRIALS study record update · 2023-08-07
Multicenter Evaluation of Diagnostic Performance of [18F]FPSMA-1007 PET/CT in Patients With Suspected Prostate Cancer
CLINICAL_TRIALS study record update · 2023-08-07
A Phase 2 Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate Cancer
CLINICAL_TRIALS study record update · 2023-08-07
Meditation and Cancer: Effectiveness of the MAEva Program on Symptoms and Quality of Life. Pilot Feasibility Study. (MAEva Pilot Study)
CLINICAL_TRIALS study record update · 2023-08-04
A Randomized Phase II Study of OGX-011 in Combination With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Patients With Metastatic Hormone Refractory Prostate Cancer
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2023-08-04
A Phase I Study of a Second Generation Clusterin Antisense Oligonucleotide (OGX-011) in Combination With Docetaxel
CLINICAL_TRIALS study record update · 2023-08-04
A Randomized Phase II Study of Reolysin in Combination With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Patients With Metastatic Castration Resistant Prostate Cancer
CLINICAL_TRIALS study record update · 2023-08-04
A Phase II Study of SB939 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
CLINICAL_TRIALS study record update · 2023-08-04
A Phase II Study Of BAY 43-9006 (NSC 724772; CTEP IND# 69,896) In Patients With Hormone Refractory Prostate Cancer
CLINICAL_TRIALS study record update · 2023-08-04
A Phase III Study of Neoadjuvant Docetaxel and Androgen Suppression Plus Radiation Therapy Versus Androgen Suppression Alone Plus Radiation Therapy for High-Risk Localized Adenocarcinoma of the Prostate
CLINICAL_TRIALS study record update · 2023-08-04
A Phase I Study Of Combination Neoadjuvant Hormone Therapy And Weekly OGX-011 (Clusterin Antisense Oligonucleotide) Prior To Radical Prostatectomy In Patients With Localized Prostate Cancer
CLINICAL_TRIALS study record update · 2023-08-03
A Phase I-II, FIH Study of A166 in Locally Advanced/Metastatic Solid Tumors Expressing Human Epidermal Growth Factor Receptor 2 (HER2) or Are HER2 Amplified That Did Not Respond or Stopped Responding to Approved Therapies
CLINICAL_TRIALS study record update · 2023-08-02
Tolerance, Safety, Pharmacokinetics, and Preliminary Anti-tumor Activity of QLH12016 in Patients With Metastatic Castration Resistant Prostate Cancer
CLINICAL_TRIALS study record update · 2023-08-02
Advanced Molecular Imaging With Anti-3-[18F]FACBC PET-CT to Improve the Selection and Outcomes of Prostate Cancer Patients Receiving Post-prostatectomy Radiotherapy
CLINICAL_TRIALS study record update · 2023-08-02
Testing Decision Aids to Improve Prostate Cancer Decisions for Minority Men
CLINICAL_TRIALS study record update · 2023-08-02
Robot-assisted Urological Surgeries Using the MicroHand S Robot: a Prospective, Single Blind, Randomized Controlled Trial
CLINICAL_TRIALS study record update · 2023-08-01
Androgen-Deprivation Therapy and Cardiovascular Risk: A Nationwide Population-based Cohort Study
CLINICAL_TRIALS study record update · 2023-08-01
Stage 2B of: A Pivotal, Prospective, Three-Stage, Single-Arm Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for a Limited-Volume, Clinically Localized, Intermediate-Risk Prostate Cancer
CLINICAL_TRIALS study record update · 2023-08-01
Exploratory Clinical Trial Using BR55 Targeted Ultrasound Contrast Agent in the Detection of Prostate Cancer by Molecular Imaging of VEGFR2
CLINICAL_TRIALS study record update · 2023-07-28
DASL-HiCaP: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (ANZUP1801): A Randomised Phase 3 Double-blind, Placebo-controlled Trial of Adding Darolutamide to Androgen Deprivation Therapy and Definitive or Salvage Radiation in Very High Risk, Clinically Localised Prostate Cancer
CLINICAL_TRIALS study record update · 2023-07-27
Prediction of the PRONOUNCE Prostate Cancer Trial in Healthcare Claims Data
CLINICAL_TRIALS study record update · 2023-07-27
Nerve-sparing, Robot-assisted Radical Prostatectomy Using a Personalized, 3D-printed Prostate Model for Selective Resection of Positive Surgical Margins
CLINICAL_TRIALS study record update · 2023-07-27
The Role of 68Ga-PSMA-11 PET in Surgery Guidance in Prostate Cancer: A Prospective Pilot Trial
CLINICAL_TRIALS study record update · 2023-07-24
A Phase III, Multicenter, Randomized, Controlled Study of Neoadjuvant LHRH-agonist Therapy and Permanent I-125 Implantation With vs. Without Adjuvant LHRH-agonist Therapy in Patients With Untreated Intermediate-risk Prostate Cancer.
CLINICAL_TRIALS study record update · 2023-07-24
Lidocaine Combined With Sufentanil for Preventing Catheter-related Bladder Discomfort After Robot-assisted Radical Prostatectomy: a Randomized, Double-blind, Controlled Trial